Tag: Exane
Latest: UBS favours downside protection
International | Industry
15 Nov 2022 by Summer Wang
The primary objective for investors in the current market environment should be capital preservation with return being a secondary consideration, according to UBS.
BNP Paribas sees structured products activity spike
International | Industry
05 Aug 2021 by SRP News
Structured products performed well in Q2 2020, especially in Japan where sales volumes increased almost tenfold, according to SRP data.
BNP Paribas, Exane hammer out takeover
International | Industry
14 Jul 2021 by SRP News
Following the announcement in March 2021, BNP Paribas is set to finalise the acquisition.
Latest: BNPP doubles down on Exane, platforms expand their reach
International | Industry
22 Mar 2021 by SRP News
After a 17-year partnership, BNP Paribas is looking to acquire up to 100% of Exane, raising its stake from the 50% currently held.
Latest: J.P. Morgan debuts prop play in US
International | Industry
28 Jan 2021 by SRP News
The investment bank has deployed a custom index not seen before in the structured products retail market via a new indexed annuity targeted at US retirement investors.
Arrivals & departures: top moves of 2020 – Leonteq
International | People
14 Jan 2021 by SRP News
As we enter 2021, SRP looks back at the most read people move stories in 2020 highlighting the changes at the main issuers and manufacturers of structured products globally. In today’s article we focus on Leonteq.
Product wrap: SocGen offers access to dividend champions via S&P index
International | Products
21 Feb 2020 by Marc Wolterink
This week’s wrap covers a selection of structured products with strike dates between February 16-22 2020.
